butyrate and glp 1 to combat obesity obesity‐associated metabolic disorders: Current status and future implications for therapeutic use - Deuren - 2022 - Obesity Reviews Engineered probiotics Clostridium butyricum‐pMTL007‐GLP‐1 improves

Make sure your Digital Nourish is in your cart with your GLP-1 program to get it free

Truveta Research tracks GLP-1 RA prescribing through March 2026, showing accelerated anti-obesity use and a sharp rise in first-time semaglutide prescribing.

Un pisode pour mieux comprendre, mieux accompagner et mieux traiter

Explore how GLP-1 medications may help manage binge eating disorder by reducing hunger and cravings

Today we announced positive topline results from the first Phase 1b clinical trial of elecoglipron conducted in China in adults living with obesity/overweight, with or without type 2 diabetes

The Semaglutide pen is a pre-filled and disposable device that administers semaglutide, the generic name for Wegovy and Ozempic